Applicant's polymathic background and platform-building resonate with Cowen's innovation philosophy. However, focus on early-career independent research in pharmacology rather than rapid-scaling ventures may not align with Emergent Ventures' apparent emphasis on economically-impactful projects. Consider if addiction-science platforms have clear market or social scaling angles.